Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kit and melanocyte migration.

James M Grichnik1

  • 1Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. grich001@mc.duke.edu

The Journal of Investigative Dermatology
|April 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Driver mutations and tumor mutational burden impact stage IV melanoma survival.

Journal of the American Academy of Dermatology·2026
Same author

Use of ancillary studies in pediatric spitzoid neoplasms: A retrospective cohort study.

Journal of the American Academy of Dermatology·2026
Same author

Topical cantharidin use in dermatology: an updated review.

Dermatology online journal·2025
Same author

Clinical Utility of a Digital Dermoscopy Image-Based Artificial Intelligence Device in the Diagnosis and Management of Skin Cancer by Dermatologists.

Cancers·2024
Same author

Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton's tyrosine kinase inhibitor.

JAAD case reports·2024
Same author

Human Hair Graying Revisited: Principles, Misconceptions, and Key Research Frontiers.

The Journal of investigative dermatology·2023
Same journal

An Integrated Skin Cell Atlas Decodes the Pilosebaceous Unit.

The Journal of investigative dermatology·2026
Same journal

Residual CSB activity explains mild UV-sensitive syndrome phenotype caused by CSB mutations.

The Journal of investigative dermatology·2026
Same journal

Charting a new melanoma risk factor: Satellite Naevus Prevalence in High-Risk and Population-Based Cohorts.

The Journal of investigative dermatology·2026
Same journal

Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris.

The Journal of investigative dermatology·2026
Same journal

Merkel cells attenuate autoantigen-specific T cell driven skin inflammation in mice associated with reduced neutrophil recruitment.

The Journal of investigative dermatology·2026
Same journal

The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.

The Journal of investigative dermatology·2026
See all related articles

A Kit-activating mutation, mitogenic in mast cells, caused melanocytes to become motogenic with reduced proliferation and differentiation. This cellular response may impact epidermal integration, nevogenesis, and melanoma development.

Area of Science:

  • Cell Biology
  • Dermatology
  • Cancer Research

Background:

  • Alexeev and Yoon introduced a Kit-activating mutation into melanocytes.
  • This mutation is known to be mitogenic in mast cells.

Discussion:

  • The mutation induced motility (motogenesis) in melanocytes, contrasting with its mitogenic effect in mast cells.
  • Melanocytes exhibited decreased proliferation and differentiation following the mutation.
  • These disparate cellular responses suggest the influence of the melanocyte cellular milieu.

Key Insights:

  • Kit-activating mutations can have distinct effects on different cell types.
  • Melanocyte behavior is sensitive to specific genetic alterations.
  • The cellular environment plays a crucial role in mediating cellular responses to mutations.

Related Experiment Videos

Outlook:

  • Investigating the cellular milieu's role in melanocyte response to Kit mutations is critical.
  • Understanding these mechanisms may offer new insights into nevogenesis and melanoma.
  • This research could inform strategies for managing melanocytic disorders and skin cancer.